IBA finalizes contract with Medtechnica Ltd for two Proteus®ONE proton therapy solutions at the Tel Aviv Sourasky Medical Center in Israel
27 Septembre 2023 - 2:00PM
IBA finalizes contract with Medtechnica Ltd for two Proteus®ONE
proton therapy solutions at the Tel Aviv Sourasky Medical Center in
Israel
Louvain-La-Neuve, Belgium, September 27,
2023 - IBA (Ion Beam
Applications S.A., EURONEXT), the world leader in particle
accelerator technology and the world’s leading provider of
proton therapy solutions for the treatment of cancer, today
announces it has signed the final contract with Medtechnica Ltd for
the installation of two Proteus®ONE1compact proton therapy
solutions at the Sourasky Medical Center (Ichilov Hospital) in Tel
Aviv, Israel. This follows the signature of a binding term
sheet previously announced in May 2023. Sourasky Medical Center has
been selected by the Israeli Ministry of Health to host the first
national proton therapy center in Israel, bringing this
cutting-edge technology to hundreds of patients per year. The
project is fully financed and IBA received the first payment in
July 2023.
The integrated solution also includes a fully
integrated quality assurance (QA) hardware and software package
from IBA Dosimetry. Once approved by regulatory authorities, IBA
will upgrade the two systems with DynamicARC®2, IBA’s unique Arc
Proton Therapy solution. The contract includes long-term operation
and maintenance services to be provided by IBA.
***ENDS***
About IBA
IBA (Ion Beam Applications S.A.) is the world
leader in particle accelerator technology. The company is the
leading supplier of equipment and services in the field of proton
therapy, considered to be the most advanced form of radiation
therapy available today. IBA is also a leading player in the fields
of industrial sterilization, radiopharmaceuticals and dosimetry.
The company, based in Louvain-la-Neuve, Belgium, employs
approximately 2,000 people worldwide. IBA is a certified B
Corporation (B Corp) meeting the highest standards of verified
social and environmental performance.
IBA is listed on the pan-European stock exchange
EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).
More information can be found at:
www.iba-worldwide.com
About Ichilov Hospital / Sourasky Medical
Center
Tel Aviv Sourasky Medical Center (Ichilov) is
the largest acute care facility in Israel, treating about 400,000
patients and hosting 1.8 million patient visits per year. A
1500-bed world-class governmental academic medical center, Tel Aviv
Sourasky Medical Center serves a population of one million people,
including residents from the greater Tel Aviv area and visitors to
the metropolis.
About Medtechnica Ltd
Founded in 1953, Medtechnica specializes in
importing, marketing, sales and technical support of medical
devices and equipment. A subsidiary of the Ilex
Group (TASE:ILX), the company partners with international
blue-chip companies healthcare professionals and purchasing
departments to provide them with holistic solutions for the Israeli
market. Our customers include HMOs, public hospitals, the Ministry
of Health, the Ministry of Defense, the Israeli Police Department,
and private health institutions and clinics, as well as
private customers.
CONTACTSSoumya
ChandramouliChief Financial Officer+32 10
475 890Investorrelations@iba-group.com
Olivier LechienCorporate
Communication Director+32 10 475 890communication@iba-group.com
Consilium Strategic
CommunicationsAmber Fennell, Matthew Neal, Lucy
Featherstone+44 (0) 20 3709 5700IBA@consilium-comms.com
1 Proteus®ONE is the brand name of Proteus®235
2 DynamicARC® is a registered brand of the IBA’s Proton Arc
therapy solution currently under development phase
- 230921-Israel-final-contract-2P1-EN
Ion Beam Applications (EU:IBAB)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Ion Beam Applications (EU:IBAB)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024